JT, Oliveira AM, Nascimento AG, et al: Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol 2012;36:517–525.
85Powers KA, Han LM, Chiu AG, Aly FZ: Low-grade sinonasal sarcoma with neural and myogenic features – diagnostic challenge and pathogenic insight. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119:e265–e269.
86Wang X, Bledsoe KL, Graham RP, et al: Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet 2014;46:666–668.
87Wong WJ, Lauria A, Hornick JL, Xiao S, Fletcher JA, Marino-Enriquez A: Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma. Genes Chromosomes Cancer 2016;55:25–29.
88Sumegi J, Streblow R, Frayer RW, et al: Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosomes Cancer 2010;49:224–236.
89Hoch BL, Nielsen GP, Liebsch NJ, Rosenberg AE: Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases. Am J Surg Pathol 2006;30:811–818.
90St Martin M, Levine SC: Chordomas of the skull base: manifestations and management. Curr Opin Otolaryngol Head Neck Surg 2003;11:324–327.
91Hug EB: Review of skull base chordomas: prognostic factors and long-term results of proton-beam radiotherapy. Neurosurg Focus 2001;10:E11.
92DeMonte F, Diaz E Jr, Callender D, Suk I: Transmandibular, circumglossal, retropharyngeal approach for chordomas of the clivus and upper cervical spine. Technical note. Neurosurg Focus 2001;10:E10.
93Colli BO, Al-Mefty O: Chordomas of the skull base: follow-up review and prognostic factors. Neurosurg Focus 2001;10:E1.
94Dehner LP, Askin FB: Tumors of fibrous tissue origin in childhood. A clinicopathologic study of cutaneous and soft tissue neoplasms in 66 children. Cancer 1976;38:888–900.
95Pena S, Brickman T, StHilaire H, Jeyakumar A: Aggressive fibromatosis of the head and neck in the pediatric population. Int J Pediatr Otorhinolaryngol 2014;78:1–4.
96Colombo C, Miceli R, Lazar AJ, et al: CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study. Cancer 2013;119:3696–3702.
97van Broekhoven DL, Verhoef C, Grunhagen DJ, et al: Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis. Ann Surg Oncol 2015;22:1464–1470.
98Mentzel T, Beham A, Calonje E, Katenkamp D, Fletcher CD: Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol 1997;21:363–374.
99Weiss SW, Enzinger FM: Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 1982;50:970–981.
100Flucke U, Vogels RJ, de Saint Aubain Somerhausen N, et al: Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases. Diagn Pathol 2014;9:131.
101Tanas MR, Sboner A, Oliveira AM, et al: Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med 2011;3:98ra82.
102Deyrup AT, Tighiouart M, Montag AG, Weiss SW: Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol 2008;32:924–927.
103Friedman CD, Costantino PD, Teitelbaum B, Berktold RE, Sisson GA Sr: Primary extracranial meningiomas of the head and neck. Laryngoscope 1990;100:41–48.
104Shibuya M: Pathology and molecular genetics of meningioma: recent advances. Neurol Med Chir (Tokyo) 2015;55:14–27.
105Thompson LD, Gyure KA: Extracranial sinonasal tract meningiomas: a clinicopathologic study of 30 cases with a review of the literature. Am J Surg Pathol 2000;24:640–650.
106Ho KL: Primary meningioma of the nasal cavity and paranasal sinuses. Cancer<italic></italic>1980;46:1442–1447.
107Broich G, Pagliari A, Ottaviani F: Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res 1997;17:2683–2706.
108Jethanamest D, Morris LG, Sikora AG, Kutler DI: Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg 2007;133:276–280.
109Platek ME, Merzianu M, Mashtare TL, et al: Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol 2011;6:41.
110Mills SE: Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol 2002;15:264–278.
111Thompson LD: Olfactory neuroblastoma. Head Neck Pathol 2009;3:252–259.
112Saade RE, Hanna EY, Bell D: Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep 2015;17:423.
113Tajudeen BA, Arshi A, Suh JD, St John M, Wang MB: Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis. JAMA Otolaryngol Head Neck Surg 2014;140:1124–1129.
114Malouf GG, Casiraghi O, Deutsch E, Guigay J, Temam S, Bourhis J: Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome. Eur J Cancer 2013;49:1324–1334.
115Hafezi S, Seethala RR, Stelow EB, et al: Ewing’s family of tumors of the sinonasal tract and maxillary bone. Head Neck Pathol 2011;5:8–16.
116Holsinger FC, Hafemeister AC, Hicks MJ, Sulek M, Huh WW, Friedman EM: Differential diagnosis of pediatric tumors of the nasal cavity and paranasal sinuses: a 45-year multi-institutional review. Ear Nose Throat J 2010;89:534–540.
117Whaley JT, Indelicato DJ, Morris CG, et al: Ewing tumors of the head and neck. Am J Clin Oncol 2010;33:321–326.
118Balatsouras DG, Eliopoulos PN, Economou CN: Multiple glomus tumours. J Laryngol Otol<italic></italic>1992;106:538–543.
119Woodruff
